Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Vera Therapeutics granted inducement awards for five new employees: options on 16,700 Class A shares and RSUs on 8,350 shares under its Inducement Plan. Options carry a $32.38 exercise price, equal to the September 29, 2026 close, with standard four-year vesting approved under Nasdaq Listing Rule 5635(c)(4).
Key figures
- Rsu shares
- 8350
- New employees
- 5
- Exercise price
- 32.38
- Options shares
- 16700
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.